arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Whitehawk Therapeutics, Inc.

WHWK
$4.75 ▲ +0.06 (+1.28%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
19 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Whitehawk Therapeutics, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $294.0M
Dividend Yield
Revenue Growth -72.5%
Op. Margin None
ROIC -83.9%
FCF / Share $-1.58
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$7.14M
↓ -72.5%
Net Income Profit after all expenses
$-20.60M
↑ +67.7%
Operating Margin Operating profit as % of sales
-259.6%
↑ +12.1%
FCF / Share Free cash flow per share
$-1.58
↑ +30.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
30
Cash Quality
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 69 quarters